论文部分内容阅读
目的 评价肝海绵状血管瘤剥除术的临床应用价值。方法 于 1979～ 1998年 ,我院对 12 6例需手术治疗的肝海绵状血管瘤实施了剥除术 ,其中多发海绵状血管瘤 18例 (14 3%) ,位于肝实质内者 6例 (4 8%) ,对直径大于 10cm和累及第Ⅰ或Ⅷ肝段的肝海绵状血管瘤同时采用了肝门间歇阻断的方法。结果 全部肝海绵状血管瘤均被成功剥除 ,无手术死亡 ,术中平均失血 (10 15± 5 77)ml〔(2 0 0～ 45 0 0 )ml〕 ,术后发生右侧胸腔反应性积液和切口感染共 15例 (11 9%) ,随访 72例 ,无复发。结论 通过与文献中的肝切除术组进行比较 ,我们体会 ,剥除术是手术治疗肝海绵状血管瘤的更安全、更有效的方法。
Objective To evaluate the clinical application of hepatic cavernous hemangiomas. Methods From 1979 to 1998, 126 cases of hepatic cavernous hemangiomas requiring surgical treatment were dissected in our hospital. Among them, 18 cases (14. 3%) were cavernous hemangiomas, and 6 cases were located in hepatic parenchyma (6 cases). 4 8%). Hepatic portal hepatic blockade was used for hepatic cavernous hemangioma with a diameter greater than 10 cm and involving the hepatic segment I or VIII. Results All of the hepatic cavernous hemangiomas were successfully removed. No operative death occurred. The average blood loss during the operation was (10 15 ± 5 77) ml (200-450 0 ml). The right thoracic cavity reactivity occurred after operation. A total of 15 cases (11 9%) of effusion and incision infection were followed up for 72 cases without recurrence. Conclusions Comparing with the literature in the liver resection group, we understand that debridement is a safer and more effective method for surgical treatment of hepatic cavernous hemangiomas.